A Safety and Tolerability Study of FCN-207 in Healthy Volunteers

NCT04622124 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

132

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperuricemia

Interventions

DRUG: Placebo
DIETARY_SUPPLEMENT: fasted vs. high-fat meal
DRUG: Placebo

Sponsor

Fochon Pharmaceuticals, Ltd.